Company Overview and News

 
Sri Lanka rupee falls to new record low: ASPI down by 1.0-pct

2018-09-18 lankabusinessonline
Sept 18, 2018 (LBO) – Sri Lanka’s rupee hit an all time low of 166.60/65 to the US dollars in mid-day trading while the islands stocks also fell below 6,000 points, Tuesday.
JKELF NEST JKH JKEHY

 
Asia Frontier Capital - Sri Lanka Travel Report

2018-09-13 seekingalpha
Infrastructure projects such as the Colombo International Financial City can help improve long term economic prospects for Sri Lanka.
DIAL CIFC FM JKELF JKH BSMAF SLTL BBRC JKEHY 1818

 
Sri Lanka stock bellwether JKH trades just Rs30,000 as market turnover dries up

2018-09-06 lankabusinessonline
September 6, 2018 (LBO) – The Colombo Stock Exchange had one of its slowest trading days in some time, the day after protests shut down the city. Although the protests were much less disruptive than feared, it still did not inspire people to come back to the stock market.
JKELF JKH JKEHY

 
JKH’s Gihan Cooray to Chair Nations Trust Bank

2018-08-30 lankabusinessonline
August 30, 2018 (LBO) – John Keells Holdings (JKH) Group Finance Director Gihan Cooray is set to take over as Chairman of Nations Trust Bank from December 1, 2018.
SEYB JKELF JKH 55BC CBQS NTB HNB SAMP JKEHY

 
CSE finishes the week lower, turnover continues to be extremely poor

2018-08-03 lankabusinessonline
August 3, 2018 (LBO) – Major indices at the Colombo Stock Exchange finished the week lower on extremely low levels of total market turnover.
JKELF JKH JKEHY

 
Sri Lanka stocks finish down, Bellwether JKH leads market lower

2018-08-01 lankabusinessonline
August 1, 2018 (LBO) – The Colombo Stock Exchange finished the trading session lower on the day, with volumes continuing to be light.
JKELF JKH JKEHY

 
Depressed consumer demand hampers John Keells first quarter

2018-07-30 dailymirror.lk
John Keells Holdings PLC (JKH), Sri Lanka’s highest valued business conglomerate, could not escape from the dampened economic activities in the country, as the group performance was hampered by its key consumer business segments.
JKL JKELF JKH UAL NTB JKEHY

 
John Keells Holdings (JKH) reports weak results, 62% of Cinnamon Life residential space sold

2018-07-29 lankabusinessonline
July 29, 2018 (LBO) – Sri Lanka’s most important listed company, John Keells Holdings (JKH) reported weak results for the quarter ended June 2018.
JKELF JKH JKEHY

 
John Keells Hotels (KHL) loses Rs263mn for the quarter, continues to be a serial underperformer

2018-07-27 lankabusinessonline
July 27, 2018 (LBO) – Colombo Stock Exchange listed John Keells Hotels (KHL) reported weak results for the quarter ended June 2018. The company lost Rs263mn in the quarter, a seasonally weak one for Sri Lanka tourism.
JKELF JKH KHL JKEHY

 
Colombo stocks finish higher for second straight week, JKH up 4%

2018-07-20 lankabusinessonline
July 20, 2018 (LBO) – The Colombo Stock Exchange closed higher for the second straight week. After several consecutive weeks of decline, the major indices have managed to string together back to back weeks of gains.
JKELF JKH JKEHY

 
Colombo stocks pop, led higher by John Keells Holdings (JKH)

2018-07-17 lankabusinessonline
July 17, 2018 (LBO) – The Colombo Stock Exchange finished markedly higher in one of the strongest days in weeks.
JKELF JKH JKEHY

 
JKH hits post war valuation lows as second Balendra era beckons

2018-07-04 lankabusinessonline
July4, 2018 (LBO) – The Colombo Stock Exchange has had a tough 2018, and there is no stock where this is more apparent than John Keells Holdings (JKH). JKH has been referred to as Sri Lanka’s bluest of blue chips.
JKELF JKH CTC NTB JKEHY

 
Colombo stocks sink to new lows with S&P SL 20 index down 10% for 2018

2018-07-03 lankabusinessonline
Key indices were both lower with the All Share Price Index (ASPI) down .77% and the S&P SL 20 down 1.34% on the session.
JKELF JKH JKEHY

 
Selling accelerates as Colombo stocks hit new lows for 2018

2018-07-02 lankabusinessonline
July 2, 2018 (LBO) – The markets started the month of July on the same course they have been for the year. The days selloff was slow and steady through the session with both major indices dropping over 1%.
JKELF JKH JKEHY

 
More pain as afternoon selloff takes Sri Lanka stocks to lowest close in 2018

2018-06-26 lankabusinessonline
June 26, 2018 (LBO) – The Colombo Stock Exchange sold off in the afternoon after being up for the first half of the session. The selloff took the market to the lowest close year to date, ahead of a poya (full moon) holiday tomorrow.
JKELF JKH JKEHY

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

6h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...